While children under five, particularly those under two, are the most vulnerable, pneumococcal diseases also affect adults. The most common symptoms include cough, chills and fever.

How do the shots help Vaccination can protect against some of these infections and can prevent complications in children. It helps address pneumococcal bacterial infections, including pneumonia ...

Pneumococcal lobar pneumonia was chosen for this study because of the relatively sharp clinical end-point obtainable. A consecutive series of patients was treated with aqueous penicillin G given ...

Background: Pneumonia is the leading cause of morbidity and mortality among children <5 years of age globally. Pneumococcal conjugate vaccines (PCVs) are known to provide protection against ...

Vaccines against certain kinds of pneumonia exist for adults, but many high-risk patients do not routinely receive them. A relatively new pneumococcal vaccine for children called Prevnar ...

Preliminary studies by Finland et al. 3 have indicated that this antibiotic is effective in the treatment of pneumococcal pneumonia and other bacterial infections and that its toxicity is low.

The vaccines achieved a 79% reduction in pneumococcal pneumonia caused by the capsular ... capsular polysaccharides in children and young adults aged 2 to 25 years with sickle cell disease ...

The CDC revised its pneumococcal pneumonia shot recommendation, saying there is a substantial increase in the risk for infection beginning at age 50.

The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive ...

A phase 2 study in children will also start ... There are around 100 different pneumococcal serotypes, causing non-invasive disease like pneumonia, confined to the lungs, and invasive disease ...

Drug major Merck & Co. (MRK) announced Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use or ...